Patients’ real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group

Autor: Maria Nachury, Yoram Bouhnik, Melanie Serrero, Jerome Filippi, Xavier Roblin, Julien Kirchgesner, Guillaume Bouguen, Denis Franchimont, Guillaume Savoye, Anthony Buisson, Edouard Louis, Stephane Nancey, Vered Abitbol, Jean-Marie Reimund, Olivier DeWit, Lucine Vuitton, Nicolas Matthieu, Laurent Peyrin-Biroulet, Cyrielle Gilletta, Sara Tadbiri, Matthieu Allez, Stephanie Viennot, Arnaud Bourreille, David Laharie, Aurelien Amiot, Charlotte Gagniere, Jenny Tannoury, Benjamin Pariente, Pauline Wils, Carmen Stefanescu, Xavier Treton, Xavier Hébuterne, Nadia Arab, Virginie Cluzeau, Emilie Del Tedesco, Laurent Beaugerie, Philippe Seksik, Anne Bourrier, Cecilia Landmann, Harry Sokol, Laurent Siproudhis, Marie DeWitte, Catherine Reenaers, Gilles Boschetti, Claire Gay, Pauline Danion, Bernard Flourié, Georgia Malamut, Benedicte Caron, Olivier DeWitt, Nicolas Mathieu, Sandie Pestour, Camille Zallot, Jean-Marc Gornet, Clotilde Baudry, Caroline Trang-Poisson, Nina Dib, Hedi Brixi, Guillaume Cadiot, Medina Boualit, Claire Painchart, Laurianne Plastaras, Romain Altwegg, Lucile Boivineau, Mathurin Fumery, Ludovic Caillo, Pauline Riviere, Florian Poullenot, Benoit Coffin, Henri Duboc, Stephane Nahon, Noemie Tavernier, Marion Simon, Baya Coulibaly, Morgane Amil, Duveau Nicolas, Sherine Khater, Mehdi Kaassis, Felix Goutorbe, Driffa Moussata, Laurence Picon

Publikováno v: Digestive and Liver Disease
Digestive and Liver Disease, 2021, 53 (4), pp.434-441. ⟨10.1016/j.dld.2020.10.020⟩
Digestive and Liver Disease, WB Saunders, 2021, 53 (4), pp.434-441. ⟨10.1016/j.dld.2020.10.020⟩
Digestive and liver disease, Vol. 53, no.4, p. 434-441 (2021)
Digestive and Liver Disease, Elsevier, 2021, 53 (4), pp.434-441. ⟨10.1016/j.dld.2020.10.020⟩

International audience; BACKGROUND: Patients’ experience with healthcare professionals could influence their clinical outcomes. AIMS: To assess inflammatory bowel disease (IBD) patients’ experience with their disease, their treatment and their re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8568cc4cd662f66fe823e34ee32bceb9
https://hal.science/hal-03038260

Clinical guidelines for the management of inflammatory bowel disease: Update of a French national consensus

Autor: Aurélien Amiot, Guillaume Bouguen, Guillaume Bonnaud, Yoram Bouhnik, Hervé Hagege, Laurent Peyrin-Biroulet, Vered Abitbol, Georgia Malamut, Aurelien Amiot, Arnaud Boruchowicz, Laurent Siproudhis, Marie DeWitte, Carmen Stefanescu, Anthony Buisson, Ludovic Caillo, Maryan Cavicchi, Nina Dib, Isabelle Etienney, Jerome Filippi, Mathurin Fumery, Felix Goutorbe, Laurent Costes, Mathias Vidon, Frédéric Heluwaert, Christophe Locher, Mehdi Kaassis, Patrick Mamou, Chloe MARTINEAU, Nicolas Mathieu, Benjamin Pariente, Pauline WILS, Stephane Nancey, Magalie Picon-Coste, Camille Zallot, Marie-Pierre Pingannaud, Xavier Roblin, Julia Roux, Melanie Serrero, Marion Simon, Florence Skinazi, Lucas Spindler, Stephanie Viennot

Publikováno v: Digestive and Liver Disease
Digestive and Liver Disease, 2021, 53 (1), pp.35-43. ⟨10.1016/j.dld.2020.10.018⟩
Digestive and Liver Disease, WB Saunders, 2021, 53 (1), pp.35-43. ⟨10.1016/j.dld.2020.10.018⟩
Digestive and Liver Disease, Elsevier, 2021, 53 (1), pp.35-43. ⟨10.1016/j.dld.2020.10.018⟩

International audience; BACKGROUND: New treatments and therapeutic approaches repeatedly emerged in the field of inflammatory bowel disease. AIM: to update the French treatment algorithms for Crohn’s disease (CD) and ulcerative colitis (UC). METHOD

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f49d9c4f1dd8026690c2452b7df814d7
https://hal.science/hal-03001613

Su1499: IMMUNOMODULATORS ARE PROTECTIVE AGAINST SEVERE COVID 19: RESULTS FROM A LARGE MULTICENTRE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS

Autor: Lucine Vuitton, Anne Bourrier, Mathieu Uzzan, Maria Nachury, Aurelien Amiot, Xavier Roblin, Matthieu Allez, Romain Altwegg, M.M. Vidon, Arnaud Bourreille, Melanie Serrero, Anne-Laure Pelletier, Jerome Filippi, Cyrielle Gilletta, Marion Simon, David Laharie, Stephane Nahon, Nicolas Duveau, Amelie Biron, Stephanie Viennot, Vered Abitbol, Yasmine Elgharabawy, Laurent Peyrin-Biroulet

Publikováno v: Gastroenterology. 162:S-601

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::18a14221a8be9225478a75a9bea54132
https://doi.org/10.1016/s0016-5085(22)61421-5

Dose-dependent beneficial effects of citrulline supplementation in short bowel syndrome in rats

Autor: Stephanie Walrand, Nathalie Neveux, Virgine Lasserre, Jean Maccario, Servane Le Plénier, Amandine Rubio, Christophe Moinard, Luc Cynober, Xavier Hébuterne, Jerome Filippi

Publikováno v: Nutrition
Nutrition, Elsevier, 2021, 85, pp.111118. ⟨10.1016/j.nut.2020.111118⟩
Nutrition, 2021, 85, pp.111118. ⟨10.1016/j.nut.2020.111118⟩

International audience; Objectives: Supplementing diet with citrulline has proved an efficient means of preserving nitrogen balance and improving nutritional status after massive intestinal resection. The aim of this study was to model the action of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94ea8786b0a91f0196bdb9185eae061c
https://pubmed.ncbi.nlm.nih.gov/33545544

Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study

Autor: Aurelien, Amiot, Melanie, Serrero, Laurent, Peyrin-Biroulet, Jerome, Filippi, Benjamin, Pariente, Xavier, Roblin, Anthony, Buisson, Carmen, Stefanescu, Caroline, Trang-Poisson, Romain, Altwegg, Philippe, Marteau, Thibaud, Vaysse, Anne, Bourrier, Stephane, Nancey, David, Laharie, Matthieu, Allez, Guillaume, Savoye, Jacques, Moreau, Lucine, Vuitton, Stephanie, Viennot, Guillaume, Bouguen, Vered, Abitbol, Mathurin, Fumery, Charlotte, Gagniere, Yoram, Bouhnik, Rodica, Gincul

Publikováno v: Alimentary Pharmacology & Therapeutics (Suppl)
Alimentary Pharmacology & Therapeutics (Suppl), 2019, 50 (1), pp.40-53. ⟨10.1111/apt.15294⟩

Cohort studies have described the short-term effectiveness and safety of vedolizumab in treating patients with Crohn's disease (CD) and ulcerative colitis (UC), but data beyond 1 year are lacking.To assess the effectiveness and safety of vedolizumab

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51ad339f3946a611837a17f66a1d3b3b
https://pubmed.ncbi.nlm.nih.gov/31165509